ARCHIVES

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Needs 100 SBIR Contracts By April 1 To Avoid Losing $5 Million; NIH Objects To DCT Comments

March 22, 1985

IOM Selects Advisors To Defense Department

February 5, 1993

Annual Report Key Element In Prevention Drive, Maquire Insists

February 2, 1979

Brachytherapy Better Than Surgery For Prostate Cancer

October 29, 2004

NCI Cooperative Groups Recognized By ASCO For 50+ Years Of Clinical Trials.

June 1, 2007

NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation

June 12, 1992